FDA approves the use of ADHD patch for teenagers

07/6/2010 | Bloomberg Businessweek

The Food and Drug Administration has approved Shire's Daytrana skin patch to treat patients ages 13 to 17 who have attention-deficit/hyperactivity disorder. The treatment is already available for children ages 6 to 12 with ADHD.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Math Specialist
PCG Education
Richmond, VA
Data Coach - Literacy
Remote, MS
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Instructional Design Specialist
Insight Education Group
Los Angeles, CA
K-12 Education Content Marketing and Social Media Coordinator
Insight Education Group
Encino,CA, CA